A short course of immunotherapy given before surgery eliminated detectable colon cancer in a majority of patients whose ...

The identification of rare genomic alterations in patients with colorectal cancer gives oncologists the opportunity to treat patients who otherwise might not have many options. When Mia Balko, 48, ...

People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds. The findings were present the at the annual meeting of the American ...

Neoadjuvant therapy for patients with metastatic colon cancer with single-organ liver or lung lesions was associated with improved overall survival in comparison with adjuvant therapy, according to ...

An interview with Dr. Nancy Baxter from the University of Melbourne in Melbourne, Australia, and Dr. Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston, MA, co-chairs on “Adjuvant Therapy ...

People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds. A combination of two experimental immunotherapy drugs plus standard ...

A new study reveals how colon cancer cells change identity, helping tumours spread to other organs and offering hope for ...

A multidisciplinary team made up of doctors and scientists from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the Institute for Research in Biomedicine (IRB Barcelona) ...

Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy A significant overall survival (OS) benefit of ...

As of 2020, more than 1.9 million people around the world were diagnosed with colorectal cancer each year, making it the third most common cancer globally. Now, a new study presented at the 2025 ...